化学
对映体
色谱法
羟基氯喹
质谱法
串联质谱法
二乙胺
检出限
液相色谱-质谱法
立体化学
有机化学
医学
病理
传染病(医学专业)
疾病
2019年冠状病毒病(COVID-19)
作者
Dong Guo,Rujian He,Wenxia Su,Ziqing Liang,Wei‐Guang Zhang,Jun Fan
出处
期刊:Chirality
[Wiley]
日期:2021-11-04
卷期号:34 (1): 126-133
被引量:2
摘要
Abstract An efficient, sensitive and selective liquid chromatography–tandem mass spectrometry (LC–MS/MS) chiral analysis method was established for determination of chloroquine and hydroxychloroquine enantiomers in rat liver microsomes. Effects of polysaccharide chiral stationary phases and basic additives on chiral separations of two analytes were discussed in detail. Amylose tris(3, 5‐dimethylphenylcarbamate)‐coated chiral stationary phase showed the best separation performance for them with acetonitrile‐diethylamine‐ethanol‐diethylamine mixture (90:0.1:10:0.1, v/v/v/v) among four chiral stationary phases. Then, multiple reaction monitoring mode was selected as the data acquisition for determination of two pairs of enantiomers. The proposed LC–MS/MS chiral analysis method was validated in terms of linearity, accuracy, precision, and specificity. Good linearity with correlation coefficient over 0.998 was obtained in the concentration range of 0.05–5 μM. Limits of quantification for chloroquine and hydroxychloroquine enantiomers were 5.0 and 1.0 nM, respectively. The recoveries ranged from 81.14% to 111.09%. The intra‐day and inter‐day relative standard deviation were less than 6.5%. Moreover, concentrations of chloroquine and hydroxychloroquine enantiomers in rat liver microsomes were determined through the proposed LC–MS/MS analysis method. After incubated with rat liver microsomes for 10 min, the enantiomeric factor of hydroxychloroquine decreased from 0.50 to 0.45 ( p < 0.001). In brief, our developed determination method for chloroquine and hydroxychloroquine enantiomers through LC–MS/MS spectrometry showed the characteristics of high‐efficiency, fast speed, and very low detection limit, and would be greatly beneficial for screening and quantitation of them in biological matrices.
科研通智能强力驱动
Strongly Powered by AbleSci AI